Clinical Trials Listing, filtered by condition | Lehigh Valley Health Network

What type of appointment are you looking for?

Appointment with

Clinical Trials

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 130 of 137 Clinical Trials

Clinical Research Trial

Lung Cancer E4512: A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients w/ Tumors Harboring the ALK Fusion Protein

A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib Versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

Doctor(s) Running This Study

Brian J. Patson, MD

Clinical Research Trial

Lung Cancer E4512: A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients w/ Tumors Harboring the ALK Fusion Protein

Doctor(s) Running This Study

Brian J. Patson, MD

Clinical Research Trial

S1922

Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma

Doctor(s) Running This Study

Maged F. Khalil, MD

Clinical Research Trial

S1922

Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma

Doctor(s) Running This Study

Maged F. Khalil, MD

Clinical Research Trial

LungMAP

A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)

Doctor(s) Running This Study

Maged F. Khalil, MD

Clinical Research Trial

LungMAP

A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)

Doctor(s) Running This Study

Maged F. Khalil, MD

Clinical Research Trial

S1501

Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer, Phase III

Doctor(s) Running This Study

Ranju Gupta, MD

Maged F. Khalil, MD

Clinical Research Trial

S1501

Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer, Phase III

Doctor(s) Running This Study

Ranju Gupta, MD

Maged F. Khalil, MD

Clinical Research Trial

Alliance A031701

ALLIANCE A031701: A PHASE II STUDY OF DOSE-DENSE GEMCITABINE PLUS CISPLATIN (DDGC) IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER WITH BLADDER PRESERVATION FOR THOSE PATIENTS WHOSE TUMORS HARBOR DELETERIOUS DNA DAMAGE

Doctor(s) Running This Study

Maged F. Khalil, MD

Clinical Research Trial

Alliance A031701

Doctor(s) Running This Study

Maged F. Khalil, MD

Find

Search LVHN Site

What type of appointment are you looking for?

Appointment with